These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7227442)

  • 1. The binding of tamoxifen to human mammary carcinoma cytosol.
    Sutherland RL; Murphy LC
    Eur J Cancer (1965); 1980 Sep; 16(9):1141-8. PubMed ID: 7227442
    [No Abstract]   [Full Text] [Related]  

  • 2. The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions.
    Nicholson RI; Syne JS; Daniel CP; Griffiths K
    Eur J Cancer (1965); 1979 Mar; 15(3):317-29. PubMed ID: 446514
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of [3H] monohydroxytamoxifen in human breast carcinoma cytosols.
    Jordan VC; Fischer AH; Rose DP
    Eur J Cancer (1965); 1981 Jan; 17(1):121-2. PubMed ID: 7262143
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiestrogenic action of 3-hydroxytamoxifen in the human breast cancer cell line MCF-7.
    Roos W; Oeze L; Löser R; Eppenberger U
    J Natl Cancer Inst; 1983 Jul; 71(1):55-9. PubMed ID: 6575210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and quantitation of antiestrogen binding sites in estrogen receptor-positive and -negative human breast cancer cell lines.
    Miller MA; Katzenellenbogen BS
    Cancer Res; 1983 Jul; 43(7):3094-100. PubMed ID: 6850618
    [No Abstract]   [Full Text] [Related]  

  • 6. Displacement by tamoxifen of the estradiol-estrogen receptor binding: a functional assay for breast cancer studies.
    Levin E; Tomchinsky S; López S
    J Steroid Biochem Mol Biol; 1990 Dec; 37(5):681-6. PubMed ID: 2278851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor assay in human mammary carcinoma with the synthetic estrogen 11beta-methoxy-17alpha-ethinyl-1,3,5(10)-estratriene-3,17beta-diol (R 2858).
    Okret S; Wrange O; Nordenskjöld B; Silfverswärd C; Gustafsson JA
    Cancer Res; 1978 Nov; 38(11 Pt 1):3904-9. PubMed ID: 568028
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of estrogen and antiestrogen binding to the cytosol and microsomes of breast tumors.
    Lopes MC; Tavares MC; Vale MG; Carvalho AP
    J Steroid Biochem Mol Biol; 1991 Sep; 39(3):343-52. PubMed ID: 1911424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a second specific estrogen binding site on estrogen receptor quantitation in human breast cancer cytosol.
    Panko WB; Clark JH
    J Steroid Biochem; 1981 Dec; 15():383-6. PubMed ID: 6175793
    [No Abstract]   [Full Text] [Related]  

  • 11. Distribution of antiestrogen-specific binding sites in normal and neoplastic mammary gland.
    Mehta RG; Cerny WL; Moon RC
    Oncology; 1984; 41(6):387-92. PubMed ID: 6504492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoresceinated estrone binding by human and mouse breast cancer cells.
    Fisher B; Gunduz N; Zheng S; Saffer EA
    Cancer Res; 1982 Feb; 42(2):540-9. PubMed ID: 7055802
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential interaction of antiestrogens with cytosol estrogen receptors.
    Black LJ; Jones CD; Goode RL
    Mol Cell Endocrinol; 1981 Apr; 22(1):95-103. PubMed ID: 7239000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity of estradiol mustard for estrogen receptors and its enzymatic degradation in uterine and breast cancer cytosols.
    Leclercq G; Deboel MC; Heuson JC
    Int J Cancer; 1976 Dec; 18(6):750-6. PubMed ID: 992905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of estrogen binding sites in mammary tumors.
    Clark JH; Watson CS; Markaverich BM; Syne JS; Panko WB
    Breast Cancer Res Treat; 1983; 3(1):61-5. PubMed ID: 6871482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.
    Monsma FJ; Katzenellenbogen BS; Miller MA; Ziegler YS; Katzenellenbogen JA
    Endocrinology; 1984 Jul; 115(1):143-53. PubMed ID: 6734512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol and tamoxifen interaction at receptor sites at 37 C.
    Fishman JH
    Endocrinology; 1983 Sep; 113(3):1164-6. PubMed ID: 6191968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (3H)Tamoxifen binding studies in dimethylbenzanthracene-induced mammary carcinomata [proceedings].
    Nicholson RI; Daniel CP; Davies P; Griffiths K
    J Endocrinol; 1977 Dec; 75(3):26P. PubMed ID: 591830
    [No Abstract]   [Full Text] [Related]  

  • 19. Physicochemical and genetic evidence for specific antiestrogen binding sites.
    Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding site.
    Berthois Y; Pons M; Dussert C; Crastes de Paulet A; Martin PM
    Mol Cell Endocrinol; 1994 Mar; 99(2):259-68. PubMed ID: 8206333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.